Full-Time

Ethics & Compliance Business Partner

Dermatology

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$174.5k - $274.2k/yr

+ Short-term Incentives + Long-term Incentives

Senior, Expert

Cambridge, MA, USA

This position is classified as 'hybrid' in accordance with Takeda's Hybrid and Remote Work policy, which implies a mix of in-office and remote work.

Category
Risk & Compliance
Legal & Compliance
Required Skills
Data Analysis
Requirements
  • Minimum of 8 years of Ethics & Compliance related experience; preferably with 5 years as part of medical device or pharmaceutical industry.
  • Bachelor's degree required; Juris Doctorate or relevant advanced degree preferred
  • Strong understanding of state and federal health care laws/regulations
  • Extensive experience with laws, regulations and industry guidance that affect the pharmaceutical industry including, but not limited to, OIG and PhRMA guidelines, healthcare standard operating procedures, anti-bribery laws, and state price reporting statute
  • Respected expert and advisor to senior management of the BU who influences and drives the Ethics & Compliance agenda for the BU
  • Exceptional skills to transform ideas into conversations and materials that resonate (presentations, written documents, email, etc.)
  • Consistently demonstrates the ability to deliver results both through self and others
  • Able to work and deliver on deadlines while managing multiple projects and priorities effectively
  • Works cross-functionally / collaborates / manages matrix - Strong leadership skills, including the ability to lead change efforts through effective communication and persuasion
  • Strong customer service skills and ability to demonstrate executive presence while interacting with all levels of management and stakeholders.
  • Demonstrated ability to read, analyze, and interpret business and regulatory information and legal advice
Responsibilities
  • Responds rapidly to changing environment and business needs, is close to the market, and encourages ethical behavior in line with Takeda's values.
  • Commits to act as a role model for Takeda's values, ethics and values-based decision making, fostering this mindset in clients, partners and team members.
  • Enables the organization to take decisions which are ethical and in line with our priorities of Patient, Trust, Reputation, and Business
  • Collaborates across all E&C teams and partners with stakeholders in Business Units / Business Functions to embed ethics and compliance as part of the way everyone works at Takeda
  • Leads implementation of E&C strategy for the USBU Dermatology Franchise by influencing senior management and other stakeholders to adhere to existing E&C principles and change behavior to new trends that Takeda establishes as best practice.
  • Maintains and further strengthens business expertise and nurtures cross functional relationships to enable a proactive, holistic and cross functional approach to risk identification.
  • Works closely with senior management and cross functional partners to align on, and implement, E&C controls to proactively manage identified risks.
  • Develops programs that empower senior management as well as home office and field-based personnel to seamlessly integrate E&C principles and Takeda Values into their day-to-day activities and leadership of others.
  • Provides E&C guidance related to company activities, such as organizational design, brand planning, needs assessments, and Incentive Compensation structures.
  • Anticipates the impact guidance to one therapeutic area could have on other areas of the USBU and proactively collaborates and communicates with the relevant stakeholders to manage this impact.
  • Demonstrates leadership within the USBU E&C organization, such as informally mentoring other team members and proactively educating other team members on relevant topics.
  • Provides leadership and guidance to senior management as well as home office and field-based personnel on interpretation of Code of Conduct, Compliance Policies, and relevant SOPs, guidance documents, and other E&C program requirements.
  • Delivers high-impact presentations to promote awareness and adherence to E&C principles and Takeda Values (e.g., sales training).
  • Collaborates with E&C Operations in the creation and delivery of various E&C initiatives.
  • Collaborates with Digital E&C to support Takeda’s digital and technology-driven initiatives.
  • Assists in developing materials for USBU Risk, Ethics and Compliance Committee (RECC) meetings including external benchmarking, internal compliance metrics – dashboards, and compliance program vision. Presents at RECC meetings where required.
  • Periodically reviews and adjusts policies and procedures to align with current Takeda Legal feedback as well as E&C team input.
  • Identifies and analyzes external trends and drives into organization where needed.
  • Performs periodic reviews of USBU E&C Policies and Procedures to ensure they are consistent with Takeda Values, OIG regulatory guidance, PhRMA Code requirements and other applicable laws, regulations and internal policies and procedures
  • External facing - Drives USBU Business Partner engagement with evolving E&C trends (PhRMA, OIG, DOJ)
  • Negotiates to create solutions in harmony with leadership and business needs.
  • Partners with the business as well as any third-party vendor to live monitor USBU business unit activities, such as field rides, speaker programs and advisory boards.
  • Researches and responds to compliance hotline/helpline questions on an as-needed basis.
Desired Qualifications
  • Juris Doctorate or relevant advanced degree preferred

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.